Century Therapeutics Executives Sell Shares Amid Market Volatility

Century Therapeutics, Inc. has reported that Senior Vice President of Finance and Operations, Carr Douglas, sold 7,043 shares on March 12, 2026 at a price of $2.55 per share. Additionally, Chief Technology and Manufacturing Officer Gregory Russotti has sold 10,076 shares on the same date at the same price.